Drug Profile
Research programme: small molecule therapeutics - Takeda/Numerate
Latest Information Update: 28 Jul 2021
Price :
$50
*
At a glance
- Originator Numerate; Takeda
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; CNS disorders; Gastrointestinal disorders
Most Recent Events
- 28 Jul 2021 No recent reports of development identified for research development in Cancer in USA
- 28 Jul 2021 No recent reports of development identified for research development in CNS-disorders in USA
- 28 Jul 2021 No recent reports of development identified for research development in Gastrointestinal-disorders in USA